Kenneth Hugh Mayer

Safety and Tolerability of Once Daily Coformulated Bictegravir, Emtricitabine, and Tenofovir Alafenamide for Postexposure Prophylaxis After Sexual Exposure.

Mayer KH, Gelman M, Holmes J, Kraft J, Melbourne K, Mimiaga MJ.

J Acquir Immune Defic Syndr. 2022 05 01. 90(1):27-32. PMID: 34991141

The cost-effectiveness of a resilience-based psychosocial intervention for HIV prevention among men who have sex with men in India.

Kazemian P, Ding DD, Scott JA, Feser MK, Biello K, Thomas BE, Dange A, Bedoya CA, Balu V, Rawat S, Kumarasamy N, Mimiaga MJ, O'cleirigh C, Weinstein MC, Kumar JP, Kumar S, Mayer KH, Safren SA, Freedberg KA.

AIDS. 2022 Apr 26. PMID: 35471644

Racial disparity in ART adherence is closed in states with high social trust: Results from the Medical Monitoring Project (MMP), 2015.

Ransome Y, Kershaw T, Kawachi I, Nash D, Mayer KH.

J Community Psychol. 2022 Apr 23. PMID: 35460588

Next Generation Pre-Exposure Prophylaxis for Young Men who have Sex with Men: Lessons from System and Provider-level barriers to oral PrEP.

Valente PK, Bauermeister JA, Lin WY, Operario D, Rusley J, Hightow-Weidman L, Mayer KH, Biello KB.

AIDS Behav. 2022 Apr 21. PMID: 35445994

Enhancing HIV Prevention With New Modalities and Routine Sexual History Discussions.

Mayer KH, Allan-Blitz LT.

JAMA. 2022 04 19. 327(15):1447-1448. PMID: 35344025

Cardiac Complications After SARS-CoV-2 Infection and mRNA COVID-19 Vaccination - PCORnet, United States, January 2021-January 2022.

Block JP, Boehmer TK, Forrest CB, Carton TW, Lee GM, Ajani UA, Christakis DA, Cowell LG, Draper C, Ghildayal N, Harris AM, Kappelman MD, Ko JY, Mayer KH, Nagavedu K, Oster ME, Paranjape A, Puro J, Ritchey MD, Shay DK, Thacker D, Gundlapalli AV.

MMWR Morb Mortal Wkly Rep. 2022 Apr 08. 71(14):517-523. PMID: 35389977

Multicenter Development and Validation of a Model for Predicting Retention in Care Among People with HIV.

Ridgway JP, Ajith A, Friedman EE, Mugavero MJ, Kitahata MM, Crane HM, Moore RD, Webel A, Cachay ER, Christopoulos KA, Mayer KH, Napravnik S, Mayampurath A.

AIDS Behav. 2022 Apr 08. PMID: 35394586

Prevention-effective adherence trajectories among transgender women indicated for PrEP in the United States: a prospective cohort study.

Cooney EE, Reisner SL, Saleem HT, Althoff KN, Beckham SW, Radix A, Cannon CM, Schneider JS, Haw JS, Rodriguez AE, Wawrzyniak AJ, Poteat TC, Mayer KH, Beyrer C, Wirtz AL.

Ann Epidemiol. 2022 Apr 06. 70:23-31. PMID: 35398255

The question of the question: impactful implementation science to address the HIV epidemic.

Geng EH, Nash D, Phanuphak N, Green K, Solomon S, Grimsrud A, Sohn AH, Mayer KH, Bärnighausen T, Bekker LG.

J Int AIDS Soc. 2022 Apr. 25(4):e25898. PMID: 35384312

Factors associated with severity of COVID-19 disease in a multicenter cohort of people with HIV in the United States, March-December 2020.

Shapiro AE, Bender Ignacio RA, Whitney BM, Delaney JA, Nance RM, Bamford L, Wooten D, Keruly JC, Burkholder G, Napravnik S, Mayer KH, Webel AR, Kim HN, Van Rompaey SE, Christopoulos K, Jacobson J, Karris M, Smith D, Johnson MO, Willig A, Eron JJ, Hunt P, Moore RD, Saag MS, Mathews WC, Crane HM, Cachay ER, Kitahata MM.

J Acquir Immune Defic Syndr. 2022 Apr 01. PMID: 35364600